Open original FDA record ↗Recall record
- FDA identifier
- Z-0879-2021
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Jan 19, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
There is potential for fractures which results in the inability to delivery therapy.
Source facts
- Action
- Boston Scientific will communicate worldwide to physician customers via a customer letter. The firm notified consignees on December 2, 2020 via customer letter notifications (Dear Healthcare Professional, Dear Healthcare Administrator, and Dear Patient) . The customers notified will be as follows: " EMBLEM Electrode Model 3501 implanting physicians/centers and/or following physicians/centers of record for the advisory population. Physicians associated with an advisory device will receive a list of affected model/serials for patients which they have implanted and/or followed or sent to their center. " Centers/facilities with EMBLEM Subcutaneous Electrode Model 3501 inventory in stock. Boston Scientific will deliver the notification by hand or email via our sales representatives or deliver the letter via Federal Express, Courier, or email. Boston Scientific will reconcile that 100% of the identified customers /customer representatives signed for the letter, or the letter has been confirmed to be delivered. Boston Scientific will post the product advisory letter on our website, within the Product Performance Resource Center located @ www.bostonscientific.com/en-US/pprc/productadvisories.html
- Initiated
- 2020-11-13
- Root cause
- Device Design
- Terminated
- 2024-07-23
- Distribution
- Worldwide distribution including US and US territories, Canada, Latin America, Europe, Middle East, Africa, and Asia-Pacific region
- Recall number
- Z-0879-2021
- Recall status
- Terminated
- CDRH record ID
- 185041
- FDA classified
- 2021-01-19
- Recall event number
- 87014